Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, University of California San Francisco
… → 1990
Fingerprint
Dive into the research topics where George E Georges is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #CRSP-AID-500: A Phase 1 Dose Evaluation Study of the Safety and Preliminary Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9–Engineered T Cells (CTX112) in Adult Subjects With Refractory Autoimmune Disease
Georges, G. E. (PD/PI)
Medpace Clinical Research LLC, CRISPR Therapeutics AG
4/17/25 → 4/17/26
Project: Research project
-
Prot #CAB-201-002: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy
Georges, G. E. (PD/PI)
Advanced Clinical LLC, Cabaletta Bio, Inc.
7/10/24 → 7/10/27
Project: Research project
-
Prot #CYTB323L12201: A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants with Severe Refractory Idiopathic Inflammatory Myopathies
Georges, G. E. (PD/PI)
Novartis Pharmaceuticals Corporation
7/1/24 → 8/1/32
Project: Research project
-
Prot #CYTB323K12201: A Phase II, Multi-Part, Three-Year, Randomized, Open-Label, Assessor-Blinded, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants with Severe R
Georges, G. E. (PD/PI)
Novartis Pharmaceuticals Corporation
4/10/24 → 3/31/30
Project: Research project
-
Prot #CAB-201-003: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis
Georges, G. E. (PD/PI), Georges, G. E. (PD/PI) & Richardson, C. L. (Co-Investigator)
Advanced Clinical LLC, Cabaletta Bio, Inc.
4/1/24 → 9/13/27
Project: Research project
-
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm Trial
Georges, G. E., Khanna, D., Wener, M. H., Mei, M. G., Mayes, M. D., Simms, R. W., Sanchorawala, V., Hosing, C., Kafaja, S., Pawarode, A., Holmberg, L. A., Kolfenbach, J., Furst, D. E., Sullivan, K. M., Huang, S., Gooley, T. & Nash, R. A., 2025, (Accepted/In press) In: Arthritis and Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease
McDonald, G. B., Landsverk, O. J. B., McGovern, D. P. B., Aasebø, A., Paulsen, V., Haritunians, T., Reims, H. M., McLaughlin, B. M., Zisman, T., Li, D., Elholm, E. T. M. M., Jahnsen, F. L., Georges, G. E. & Gedde-Dahl, T., Jan 15 2024, In: Heliyon. 10, 1, e24026.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data
Keyes-Elstein, L., Pinckney, A., Goldmuntz, E., Welch, B., Franks, J. M., Martyanov, V., Wood, T. A., Crofford, L., Mayes, M., McSweeney, P., Nash, R., Georges, G., Csuka, M. E., Simms, R., Furst, D., Khanna, D., Clair, E. W. S., Whitfield, M. L. & Sullivan, K. M., Feb 2023, In: Arthritis Care and Research. 75, 2, p. 307-316 10 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Remission of severe myasthenia gravis after autologous stem cell transplantation
Schlatter, M. I., Yandamuri, S. S., O'Connor, K. C., Nowak, R. J., Pham, M. C., Obaid, A. H., Redman, C., Provost, M., McSweeney, P. A., Pearlman, M. L., Tees, M. T., Bowen, J. D., Nash, R. A. & Georges, G. E., Nov 2023, In: Annals of clinical and translational neurology. 10, 11, p. 2105-2113 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders
Marsh, R. A., Hebert, K., Kim, S., Dvorak, C. C., Aquino, V. M., Baker, K. S., Chellapandian, D., Dávila Saldaña, B., Duncan, C. N., Eckrich, M. J., Georges, G. E., Olson, T. S., Pulsipher, M. A., Shenoy, S., Stenger, E., Lugt, M. V., Yu, L. C., Gennery, A. R. & Eapen, M., Mar 2022, In: Journal of Allergy and Clinical Immunology. 149, 3, p. 1097-1104.e2Research output: Contribution to journal › Article › peer-review
Open Access29 Scopus citations